Late Entry to HIV Care Limits the Impact of Anti-Retroviral Therapy in the Netherlands

Colette Smit, Timothy B. Hallett, Joep Lange et al. · 2008

Read Late Entry to HIV Care Limits the Impact of Anti-Retroviral Therapy in the Netherlands by Colette Smit, Timothy B. Hallett, Joep Lange et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001949.txt.

Description

Colette Smit and co-authors modeled why HIV patients fare differently across Dutch clinics, in a 2008 PLOS ONE study. Once drug therapy starts, survival in the first three years varied by treatment center. One suspect was timing: how late people enter care after infection sets the stage for all that follows.

The team built a math simulation fed with data from the ATHENA cohort, a national record of HIV patients. As the title states, late entry to care limits what therapy can achieve. The model shows how much of the gap between clinics is set before the first dose is ever given.

Catalog record

CREATORColette Smit, Timothy B. Hallett, Joep Lange et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001949

Browse the full library · About the Tower of Babel